| scholarly article | Q13442814 |
| P50 | author | Michael Bockmayr | Q56953643 |
| Stefan Rutkowski | Q90355738 | ||
| Malte Mohme | Q123165863 | ||
| Ulrich Schüller | Q47460819 | ||
| P2093 | author name string | Jan Budczies | |
| Frederick Klauschen | |||
| Beate Winkler | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data | Q24537656 | ||
| Molecular subgroups of medulloblastoma: the current consensus | Q24615271 | ||
| Dissecting the genomic complexity underlying medulloblastoma | Q24621907 | ||
| Gene Expression Omnibus: NCBI gene expression and hybridization array data repository | Q27860523 | ||
| The blockade of immune checkpoints in cancer immunotherapy | Q27860852 | ||
| Subgroup-specific structural variation across 1,000 medulloblastoma genomes | Q28271811 | ||
| The therapeutic potential of natural killer cells to target medulloblastoma | Q89367141 | ||
| Signatures of mutational processes in human cancer | Q29547191 | ||
| affy--analysis of Affymetrix GeneChip data at the probe level | Q29547353 | ||
| The immune contexture in human tumours: impact on clinical outcome | Q29620667 | ||
| Frozen robust multiarray analysis (fRMA). | Q33696495 | ||
| T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. | Q34131508 | ||
| The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis | Q34188723 | ||
| New horizons in tumor microenvironment biology: challenges and opportunities | Q35151324 | ||
| Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study | Q36222126 | ||
| Robust enumeration of cell subsets from tissue expression profiles | Q36539395 | ||
| Understanding the cognitive impact on children who are treated for medulloblastoma | Q36747791 | ||
| Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype | Q36792016 | ||
| The prognostic landscape of genes and infiltrating immune cells across human cancers | Q36857285 | ||
| Risk stratification of childhood medulloblastoma in the molecular era: the current consensus | Q36901551 | ||
| Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma. | Q37040617 | ||
| Characterization of distinct immunophenotypes across pediatric brain tumor types | Q37308164 | ||
| Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity | Q37313139 | ||
| Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression | Q37356734 | ||
| Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas | Q37435455 | ||
| Control of inflammation by stromal Hedgehog pathway activation restrains colitis. | Q37450945 | ||
| Medulloblastomics: the end of the beginning | Q37469904 | ||
| Medulloblasoma: challenges for effective immunotherapy | Q37968929 | ||
| Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours | Q38148501 | ||
| PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy | Q38361400 | ||
| Tumor infiltrating immune cells in gliomas and meningiomas. | Q38555703 | ||
| Prognostic role of tumour-infiltrating inflammatory cells in brain tumours: literature review | Q38592194 | ||
| Intertumoral Heterogeneity within Medulloblastoma Subgroups | Q38671456 | ||
| Immune classifications with cytotoxic CD8+ and Th17 infiltrates are predictors of clinical prognosis in glioblastoma | Q38691992 | ||
| The Microenvironmental Landscape of Brain Tumors | Q39178065 | ||
| Wnt/beta-catenin pathway: modulating anticancer immune response | Q39286193 | ||
| Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies | Q41654251 | ||
| Spatial heterogeneity in medulloblastoma | Q41969132 | ||
| TH1 predominance is associated with improved survival in pediatric medulloblastoma patients | Q45797420 | ||
| Tumor-associated macrophages in SHH subgroup of medulloblastomas | Q46117209 | ||
| Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues | Q46308773 | ||
| Treatment of early childhood medulloblastoma by postoperative chemotherapy alone | Q46367739 | ||
| The whole-genome landscape of medulloblastoma subtypes | Q46567834 | ||
| Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma. | Q52733768 | ||
| High programmed cell death 1 ligand-1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma. | Q54160125 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| medulloblastoma | Q1333608 | ||
| P304 | page(s) | e1462430 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | OncoImmunology | Q18026500 |
| P1476 | title | Subgroup-specific immune and stromal microenvironment in medulloblastoma | |
| P478 | volume | 7 |
| Q99237709 | CAR T Cell Therapy for Pediatric Brain Tumors |
| Q101410017 | CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model |
| Q90029561 | Immunotherapy for pediatric brain tumors: past and present |
| Q91596369 | Medulloblastoma |
| Q90235802 | Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization |
| Q90270316 | Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma |
| Q98784867 | Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity |
| Q89965816 | Tumor-Specific T Cell Activation in Malignant Brain Tumors |
Search more.